NorTrials networking event at ESC 2025
29.08.2025, 12:30 - 14:30 GMT
Seminar
Norway, through NorTrials and Innovation Norway, is bringing the international pharma industry together with the Norwegian specialist healthcare system, held in connection with ESC Congress 2025 in Madrid — where we’ll explore how Norway is advancing the future of cardiovascular clinical trials through precision medicine, cutting-edge infrastructure and a nationally coordinated strategy.
Why Norway?
Norway is advancing as a strategic partner for clinical trials — with world-class infrastructure, renowned medical expertise and a strong national commitment to innovation in cardiology and precision medicine.
This session highlights Norway’s strengths in clinical research and our new national strategy to become a leading country of excellence for cardiovascular trials.
“Participation is by direct invitation only — please register your interest by 15 August 2025.”
Who you will meet?
- The Norwegian healthcare system
- Industry leaders from Norway’s life sciences sector
- NorTrials – Norway’s national entry point for global trial sponsors
- Innovation Norway
What Sets Norway Apart?
- Internationally recognised clinicians and clinical trial units
- Unique access to integrated health registries and biobanks
- National infrastructure for precision and molecular diagnostics
- Strong public-private collaboration models
- High patient engagement and trial participation rates
- A well-structured, high-performing specialist health system
Meet us to learn how Norway’s coordinated approach is unlocking new possibilities for international trial sponsors — and why the next generation of cardiovascular trials might just start north of the ordinary.
